levETIRAcetam 250 MG Oral Tablet
- RxCUI
- 311288
- RxNorm name
- levETIRAcetam 250 MG Oral Tablet
- Display name
- levETIRAcetam 250 MG Oral Tablet
- Full name
- levETIRAcetam 250 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:10
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levetiracetam | LEVETIRACETAM | Cardinal Health 107, LLC | 0348fec4-d919-4307-ac90-35360819bc00 | 2026-09-04 | Warnings, Adverse reactions | 311288 |
| Levetiracetam | LEVETIRACETAM | REMEDYREPACK INC. | 2d307850-0ed5-4f32-ac62-0e1e2fe27a7a | 2026-09-03 | Warnings, Adverse reactions | 311288 |
| Levetiracetam | LEVETIRACETAM | Ascend Laboratories, LLC | 591dd9f1-3681-4b2f-b096-7536826e3648 | 2026-08-19 | Warnings, Adverse reactions | 311288 |
| Levetiracetam | LEVETIRACETAM | Preferred Pharmaceuticals, Inc. | 419b3dba-ae21-4268-ac8b-342aaa609554 | 2026-05-18 | Warnings, Adverse reactions | 311288 |
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | c4a3018a-3cd8-4e07-a840-099ceae01c91 | 2026-05-15 | Warnings, Adverse reactions | 311288 |
| Levetiracetam | LEVETIRACETAM | Lupin Pharmaceuticals, Inc. | df661166-325d-4071-9bc1-f7bf992996d2 | 2026-05-11 | Warnings, Adverse reactions | 311288 |
| Levetiracetam | LEVETIRACETAM | ASCLEMED USA INC. | a3c57d82-511c-4c7d-84ff-f791f931f576 | 2026-05-07 | Warnings, Adverse reactions | 311288 |
| Levetiracetam | LEVETIRACETAM | Coupler LLC | 5037a86a-21f2-d793-e063-6394a90a2cb5 | 2026-04-24 | Warnings, Adverse reactions | 311288 |
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | 9e3171c9-70e2-4725-8aca-c7f83773940d | 2026-04-02 | Warnings, Adverse reactions | 311288 |
| Levetiracetam | LEVETIRACETAM | Sun Pharmaceutical Industries, Inc. | bf412e94-ca36-4da9-83d7-fb0f1323cf21 | 2026-03-23 | Warnings, Adverse reactions | 311288 |
| LEVETIRACETAM | LEVETIRACETAM | DIRECT RX | c3b62114-a590-f4db-e053-2995a90a9d30 | 2026-03-05 | Warnings, Adverse reactions | 311288 |
| Keppra | LEVETIRACETAM | UCB, Inc. | 3ca9df05-a506-4ec8-a4fe-320f1219ab21 | 2026-01-28 | Warnings, Adverse reactions | 311288 |
| Levetiracetam | LEVETIRACETAM | Cranbury Pharmaceuticals, LLC | b1e988f7-8bbe-4ef4-8b0a-b2a8af8a482b | 2025-12-28 | Warnings, Adverse reactions | 311288 |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | 01aef7f7-6092-4e39-8451-dc02d8db9254 | 2025-11-21 | Warnings, Adverse reactions | 311288 |
| Levetiracetam | LEVETIRACETAM | Quallent Pharmaceuticals Health LLC | 3756f052-919c-4817-a56e-1091fd514d9d | 2025-10-07 | Warnings, Adverse reactions | 311288 |
| Levetiracetam | LEVETIRACETAM | NorthStar RxLLC | 3884cb76-822b-400d-9b24-49c286c9b6f7 | 2025-10-07 | Warnings, Adverse reactions | 311288 |
| Levetiracetam | LEVETIRACETAM | SOHM, Inc. | 0a688786-879b-4e27-a46a-5c86bbfa1292 | 2025-09-19 | Warnings, Adverse reactions | 311288 |
| Levetiracetam | LEVETIRACETAM | Major Pharmaceuticals | c4b27429-50a3-467c-a5ff-7e49a01a1088 | 2025-09-11 | Warnings, Adverse reactions | 311288 |
| Levetiracetam | LEVETIRACETAM | Rising Pharma Holdings, Inc. | db423b93-d7c2-4cf2-829b-24b657f27f93 | 2025-08-20 | Warnings, Adverse reactions | 311288 |
| Levetiracetam | LEVETIRACETAM | OWP Pharmaceuticals, Inc. | e662bf5b-c81c-4bcd-ba2e-552df95ca6f9 | 2025-05-15 | Warnings, Adverse reactions | 311288 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a3c57d82-511c-4c7d-84ff-f791f931f576 | levETIRAcetam 250 MG Oral Tablet [PSN] · levetiracetam 250 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use LEVETIRACETAM tablets safely and effectively. See full prescribing information for LEVETIRACETAM tablets. LEVETIRACETAM tablets, for oral use Initial U.S. Approval: 1999 | 20260507 |
| 5037a86a-21f2-d793-e063-6394a90a2cb5 | levETIRAcetam 250 MG Oral Tablet [PSN] · levetiracetam 250 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use LEVETIRACETAM TABLETS safely and effectively. See full prescribing information for LEVETIRACETAM TABLETS. LEVETIRACETAM tablets, for oral use Initial U.S. Approval: 1999 | 20260424 |
| 57f09129-7151-4a75-9d73-9dd32f74ba43 | levETIRAcetam 250 MG Oral Tablet [PSN] · levetiracetam 250 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use LEVETIRACETAM TABLETS safely and effectively. See full prescribing information for LEVETIRACETAM TABLETS. LEVETIRACETAM tablets, for oral use Initial U.S. Approval: 1999 | 20240327 |
| 80f5349c-3910-4c69-9f56-cb552bf4f336 | levETIRAcetam 250 MG Oral Tablet [PSN] · levetiracetam 250 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use levetiracetam tablets safely and effectively. See full prescribing information for levetiracetam tablets. Levetiracetam Tablets USP, for oral use Initial U.S. Approval: 1999 | 20140106 |
| f217dbac-8f63-45eb-a871-9fbe2e784711 | levETIRAcetam 250 MG Oral Tablet [PSN] · levetiracetam 250 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use levetiracetam tablets safely and effectively. See full prescribing information for levetiracetam tablets USP. Levetiracetam Tablets USP for Oral Use Initial U.S. Approval: 1999 | 20130820 |
| b9acd365-1b80-4428-bd33-3a5eac814677 | levETIRAcetam 250 MG Oral Tablet [PSN] · levetiracetam 250 MG Oral Tablet [SCD] | 2 | 1 | Levetiracetam Tablets | 20110105 |
| 76c7e13d-37a0-4131-a1f1-fd5af0f60d3e | levETIRAcetam 250 MG Oral Tablet [PSN] · levetiracetam 250 MG Oral Tablet [SCD] | 2 | 1 | Levetiracetam | 20100930 |